Ouch! Another gene therapy setback as biotech halts 200-job Durham facility


Taysha Gene Therapies has stopped work on a planned $75 million investment in Durham.

Previous Inspira Health posts $42.7M loss, investments in people and places continue
Next BrewDog brings in Dutch Bros. Coffee executive as its next U.S. boss